December 2017 Briefing - HIV & AIDS

Here are what the editors at HealthDay consider to be the most important developments in HIV & AIDS for December 2017. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.

Psychosocial Risk in Teens Tied to Lasting HIV Vulnerability

THURSDAY, Dec. 28, 2017 (HealthDay News) -- High-frequency psychosocial risk factors during adolescence have a lasting effect on the likelihood of engaging in HIV risk behaviors in adulthood, according to a study published online Dec. 12 in AIDS.

Abstract/Full Text (subscription or payment may be required)

Hepatitis B Vaccination Often Missed Among HIV Patients

TUESDAY, Dec. 26, 2017 (HealthDay News) -- More than one-third of adult U.S. HIV patients miss opportunities to initiate hepatitis B vaccination, according to a study published online Dec. 26 in the Annals of Internal Medicine.

Abstract/Full Text (subscription or payment may be required)

CDC: 2015 to 2016 Saw Drop in Life Expectancy in United States

THURSDAY, Dec. 21, 2017 (HealthDay News) -- From 2015 to 2016, life expectancy decreased by one-tenth of a year, and there was an increase in the rate of age-adjusted drug overdose deaths, according to two December data briefs published by the U.S. Centers for Disease Control and Prevention's National Center for Health Statistics.

Abstract/Full Text - Kochanek
Abstract/Full Text - Hedegaard

Primary Care Crucial for Preventing New HIV Infections

TUESDAY, Dec. 19, 2017 (HealthDay News) -- Primary care providers will play an important role in preventing the next wave of HIV infections, according to a report published in Medical Economics.

More Information

Male U.S. Doctors Receive Higher Values of Industry Payments

MONDAY, Dec. 18, 2017 (HealthDay News) -- Male physicians in the United States received higher values of general payments from industry than females in 2015, according to a research letter published online Dec. 18 in JAMA Internal Medicine.

Abstract/Full Text

Year One Results Out for Value-Based Payment Modifier Program

MONDAY, Dec. 18, 2017 (HealthDay News) -- Almost 30 percent of eligible practices failed to register and report data in the first year of the Physician Value-Based Payment Modifier program, according to a report published in the December issue of Health Affairs.

Abstract/Full Text (subscription or payment may be required)

Doctors Must Report on at Least 1 Patient, 1 Measure for MACRA

FRIDAY, Dec. 15, 2017 (HealthDay News) -- In order to meet the 2017 Medicare and CHIP Reauthorization Act (MACRA) participation reporting deadline and avoid a Medicare payment penalty in 2019, physicians must report on at least one patient and one measure by Dec. 31, and submit to Medicare no later than Feb. 28, 2018, according to a report from the American Medical Association (AMA).

More Information

Making Insurers Participate in Marketplace Could Cut Volatility

THURSDAY, Dec. 14, 2017 (HealthDay News) -- Requiring insurers that participate in Medicare or Medicaid to also participate in Marketplaces in the same geographic area could improve access to insurance, according to a study published in the December issue of Health Affairs.

Abstract/Full Text (subscription or payment may be required)

Recent Change in Spectrum of HIV-Linked Kidney Disease

THURSDAY, Dec. 14, 2017 (HealthDay News) -- The spectrum of HIV-associated kidney disease has changed with the improvement of therapy for HIV infection, according to a review article published in the Dec. 14 issue of the New England Journal of Medicine.

Abstract/Full Text (subscription or payment may be required)

Deceleration in Health Care Spending Growth in 2016

MONDAY, Dec. 11, 2017 (HealthDay News) -- Health care spending growth slowed in 2016 following faster growth in 2014 and 2015, according to research published online Dec. 6 in Health Affairs.

Full Text

CVS-Aetna Merger Has Implications for Doctors' Offices

TUESDAY, Dec. 5, 2017 (HealthDay News) -- CVS Health's planned purchase of insurance giant Aetna, a $69 billion deal, was announced Sunday.

More Information - NYT
More Information - HealthDay

Nivolumab May Induce Successful Depletion of HIV Reservoir

MONDAY, Dec. 4, 2017 (HealthDay News) -- Nivolumab treatment for non-small-cell lung cancer may induce successful depletion of HIV reservoir, according to a letter to the editor published online Dec. 1 in the Annals of Oncology.

Abstract/Full Text

Physician’s Briefing Staff

Physician’s Briefing Staff

Published on January 02, 2018

Read this Next
About UsOur ProductsCustom SolutionsHow it’s SoldOur ResultsDeliveryContact UsBlogPrivacy PolicyFAQ